aspartic acid has been researched along with Cancer of Gastrointestinal Tract in 6 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (16.67) | 18.7374 |
1990's | 3 (50.00) | 18.2507 |
2000's | 1 (16.67) | 29.6817 |
2010's | 1 (16.67) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Berner, JM; Bruland, ØS; Holm, R; Joensuu, H; Kristian, A; Malinen, E; Revheim, ME; Seierstad, T | 1 |
Arbuck, SG; Balis, F; Chisena, T; Cysyk, R; Drake, J; Grem, JL; Hamilton, JM; McAtee, N; Murphy, RF; Steinberg, SM | 1 |
Allegra, CJ; Chabuk, C; Chen, AP; Grabenc, M; Grem, JL; Grollman, F; Hamilton, JM; Schuler, B; Takimoto, CH; Yee, LK | 1 |
Ardalan, B; Benedetto, P; Feun, L; Fodor, M; Livingstone, A; Morrell, L; Richman, S; Savaraj, N; Sridhar, KS; Waldman, S | 1 |
Abe, M; Ishibashi, T; Kobayashi, K; Nagata, Y; Nakayama, E; Naoe, T; Shiku, H; Yoshida, K | 1 |
Fink, E; Kronberger, L | 1 |
2 trial(s) available for aspartic acid and Cancer of Gastrointestinal Tract
Article | Year |
---|---|
A phase I study of continuous infusion 5-fluorouracil plus calcium leucovorin in combination with N-(phosphonacetyl)-L-aspartate in metastatic gastrointestinal adenocarcinoma.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Aspartate Carbamoyltransferase; Aspartic Acid; Female; Fluorouracil; Gastrointestinal Neoplasms; Humans; Infusions, Intravenous; Leucovorin; Male; Middle Aged; Monocytes; Neoplasm Metastasis; Phosphonoacetic Acid | 1993 |
A phase I, II study of high-dose 5-fluorouracil and high-dose leucovorin with low-dose phosphonacetyl-L-aspartic acid in patients with advanced malignancies.
Topics: Adult; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Aspartic Acid; Breast Neoplasms; Drug Evaluation; Female; Fluorouracil; Gastrointestinal Diseases; Gastrointestinal Neoplasms; Humans; Leucovorin; Lung Neoplasms; Male; Middle Aged; Neoplasms; Phosphonoacetic Acid; Prognosis | 1991 |
4 other study(ies) available for aspartic acid and Cancer of Gastrointestinal Tract
Article | Year |
---|---|
Intermittent and continuous imatinib in a human GIST xenograft model carrying KIT exon 17 resistance mutation D816H.
Topics: Amino Acid Substitution; Animals; Antineoplastic Agents; Aspartic Acid; Benzamides; Drug Administration Schedule; Drug Resistance, Neoplasm; Gastrointestinal Neoplasms; Gastrointestinal Stromal Tumors; Histidine; Humans; Imatinib Mesylate; Mice; Mice, Nude; Mutation, Missense; Piperazines; Proto-Oncogene Proteins c-kit; Pyrimidines; Xenograft Model Antitumor Assays | 2013 |
N-(phosphonacetyl)-L-aspartate and calcium leucovorin modulation of fluorouracil administered by constant rate and circadian pattern of infusion over 72 hours in metastatic gastrointestinal adenocarcinoma.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Aspartate Carbamoyltransferase; Aspartic Acid; Chronotherapy; Female; Fluorouracil; Gastrointestinal Neoplasms; Humans; Infusions, Intravenous; Leucovorin; Male; Middle Aged; Phosphonoacetic Acid | 2001 |
Glycine to aspartic acid mutations at codon 13 of the c-Ki-ras gene in human gastrointestinal cancers.
Topics: Aspartic Acid; Base Sequence; DNA, Neoplasm; Gastrointestinal Neoplasms; Genes, ras; Glycine; Humans; Molecular Sequence Data; Mutation; Oligonucleotide Probes; Polymerase Chain Reaction; Proto-Oncogene Proteins; Proto-Oncogene Proteins p21(ras) | 1990 |
[Asparagine and aspartic acid in the blood in malignant and benign diseases].
Topics: Adult; Aged; Asparagine; Aspartic Acid; Bronchial Neoplasms; Cholecystitis; Female; Gastrointestinal Diseases; Gastrointestinal Neoplasms; Hernia; Humans; Male; Middle Aged; Pancreatitis; Sigmoid Neoplasms; Stomach Ulcer | 1969 |